Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

NCT07558200 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Non-Small Cell Lung Cancer
Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Intervention1：FXB0871
BIOLOGICAL: Intervention2：FXB0871
BIOLOGICAL: Intervention3：FXB0871
BIOLOGICAL: Intervention4：FXB0871

Sponsor

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.